大豆基嬰幼兒配方奶粉市場－全球產業規模、佔有率、趨勢、機會與預測：按形態、類型、通路、地區和競爭格局分類，2021-2031年

全球大豆嬰兒配方奶粉市場預計將從 2025 年的 3.0832 億美元成長到 2031 年的 4.0554 億美元，複合年成長率為 4.67%。

大豆配方奶粉是專為嬰兒設計的營養替代品，採用強化大豆分離蛋白，為患有半乳糖血症、遺傳性乳糖酶缺乏症或牛奶蛋白過敏的嬰兒提供全面的營養補充方案。該領域的成長主要受乳糖不耐受診斷病例增加以及越來越多的父母傾向於選擇符合倫理或植物性飲食的生活方式的推動。植物性食品協會的報告也印證了這個趨勢：預計到2024年，美國植物性食品產業的銷售額將達到81億美元，顯示消費者正大力轉向無乳製品選擇。這為支撐大豆配方奶粉的需求奠定了基礎。

儘管市場趨勢向好，但大豆蛋白中天然存在的植物雌激素可能產生的生物學效應，給該行業帶來了重大挑戰。由於擔心荷爾蒙發育和內分泌紊亂，醫療保健專業人員和監管機構經常警告不要給六個月以下的嬰兒使用奶粉配方奶粉。由於嚴格審查，大豆配方奶粉仍然是水解牛奶配方奶粉的次要替代品，難以成為主流餵食方案，只能作為一種小眾的醫療或生活方式選擇。

市場促進因素

牛奶蛋白過敏和乳糖不耐症的日益普遍是推動豆基嬰兒奶粉持續普及的關鍵臨床因素。豆基奶粉是無法代謝乳蛋白或乳糖的嬰兒的標準替代品，能夠提供必要的營養保護，尤其適用於非IgE介導的過敏症（症狀主要影響消化器官系統的類型）。專注於特殊治療產品的行業領導企業表現出色，進一步強化了這項醫療需求。根據Food Navigator發布的2025年2月全年財報，達能特種營養品部門的銷售額成長了4.6%，凸顯了消費者對專門用於應對這些食物過敏的配方奶粉的持續依賴。

同時，父母對植物來源和純素嬰幼兒營養品的興趣日益濃厚，正推動市場從單純的醫療需求拓展至生活風格領域。現代父母越來越重視潔淨標示、永續性和不含動物成分的營養，這促使生產商加強供應鏈運營，並提升非乳製品替代品的商業性可行性。這種向道德消費的轉變正在提升營運效率。例如，Else Nutrition在2025年11月公佈的第三季收益成長了34%，顯示植物來源領域的財務狀況日趨成熟。此外，雅培2025年報告顯示，2024年全年銷售額達到420億美元，展現了龐大的市場規模，這不僅支持了全球兒童營養領域的創新，也顯示整個產業仍在大規模運作。

市場挑戰

大豆蛋白中所含的植物雌激素因其潛在的生物效應，對全球大豆嬰兒配方奶粉市場的成長構成重大阻礙。由於這些化合物會模擬天然雌激素的作用，監管機構和醫療專業人士嚴格限制此類產品的使用，因為它們可能對嬰兒的內分泌系統和長期荷爾蒙發育產生不利影響。這種醫學上的謹慎使得大豆配方奶粉幾乎不可能作為主流的植物性飲食選擇進行銷售，而是被視為最後的營養治療手段。

因此，大豆配方奶粉通常被排除在六個月以下嬰兒的標準護理之外，這大大縮小了潛在消費群體。此外，由於大豆製品通常僅用於治療特定疾病而非日常保健，市場也面臨其他限制。根據英國營養師協會2024年的數據顯示，嬰兒牛奶蛋白過敏的盛行率估計僅為2%，但即使在這一小部分族群中，由於上述安全隱患，臨床指引通常也建議使用水解配方奶粉而非大豆配方奶粉。這種監管優先性使得該產品成為小眾醫療干預措施，而非一種廣泛可用的營養選擇，從而限制了其市場規模。

市場趨勢

全球大豆嬰幼兒奶粉市場的一項重大發展是益生元和益生菌的添加。這直接解決了人們長期以來對植物蛋白消化率低於母乳的擔憂。製造商擴大在大豆分離蛋白中添加人類乳寡糖 (HMO) 和特定菌株，以提高營養吸收率並最佳化嬰幼兒腸道菌叢。這使得這些產品從單純的過敏原規避工具轉變為功能性營養解決方案。對先進配方的關注正在加強原料供應鏈。例如，帝斯曼-菲美意公司 (DSM-Firmenich) 於 2025 年 2 月報告稱，其健康、營養與護理業務部門在 2024 年實現了 6% 的有機銷售成長，這主要得益於對 HMO 等嬰幼兒必需營養成分需求的成長。

同時，採購有機種植和非基因改造大豆的戰略方向也明顯轉變。這主要源自於父母對透明度的強烈需求，以及他們對嬰幼兒食品中合成農藥的抗拒。由於大豆通常與基因改造聯繫在一起，高階品牌正日益採用嚴格的有機認證供應鏈，以降低消費者的健康擔憂，並在競爭激烈的市場中脫穎而出。這一趨勢對品類成長產生了顯著影響；根據有機貿易協會2025年4月發布的報告，有機嬰幼兒食品和配方奶粉產業在2024年實現了16億美元的銷售額，鞏固了其作為有機食品行業第二大品類的地位。這表明，對於生產商而言，獲得潔淨標示大豆認證在商業性至關重要。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：大豆嬰幼兒配方奶粉的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依型態（粉末、液體、半液體）
  • 依類型（低脂大豆嬰兒配方奶粉，全脂大豆嬰兒配方奶粉）
  • 分銷通路（線上、線下）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美大豆嬰兒配方奶粉市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲大豆嬰幼兒配方奶粉市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區大豆嬰幼兒配方奶粉市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲大豆嬰兒配方奶粉市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲大豆嬰兒配方奶粉市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球大豆嬰幼兒配方奶粉市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Danone SA
• HiPP GmbH & Co. Vertrieb KG
• Nestle SA
• Abbott Laboratories
• The Kraft Heinz Company
• Reckitt Benckiser Group PLC
• Heilongjiang Feihe Dairy Co., Ltd.
• Arla Foods amba
• Kerry Group plc
• Royal FrieslandCampina NV

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Soy Based Infant Formula Market is projected to expand from USD 308.32 Million in 2025 to USD 405.54 Million by 2031, registering a CAGR of 4.67%. Designed as a specialized nutritional alternative, soy-based infant formula utilizes soy protein isolate fortified with vital nutrients to serve as a comprehensive feeding solution for babies suffering from galactosemia, hereditary lactase deficiency, or allergies to cow's milk protein. Growth in this sector is largely sustained by increasing diagnoses of dairy intolerances and a rising parental preference for ethical or plant-centric lifestyles. Highlighting this trend, the Plant Based Foods Association reported that the United States plant-based foods sector generated $8.1 billion in sales in 2024, demonstrating a robust consumer transition toward dairy-free options that underpins the demand for soy formulations.

Despite these favorable market forces, the industry encounters significant hurdles related to the potential biological effects of phytoestrogens naturally found in soy protein. Due to apprehensions regarding hormonal development and endocrine disruption, medical authorities and regulatory agencies frequently advise caution against using soy formula for infants under six months of age. Consequently, this scrutiny restricts the product to a secondary alternative behind hydrolyzed cow's milk formulas, preventing it from becoming a mainstream feeding solution and keeping it positioned as a niche medical or lifestyle option.

Market Driver

The escalating prevalence of Cow's Milk Protein Allergy and Lactose Intolerance serves as the principal clinical factor fueling the continued adoption of soy-based infant formulations. Functioning as the standard substitute for infants incapable of metabolizing dairy proteins or lactose, soy formula offers an essential nutritional safeguard, specifically for those with non-IgE mediated allergies where symptoms primarily impact the gastrointestinal system. This medical imperative is further strengthened by the strong performance of industry leaders focusing on specialized therapeutic products; according to Food Navigator's coverage of Danone's full-year results in February 2025, the company's specialized nutrition division recorded a 4.6% increase in sales, underscoring persistent consumer dependence on formulations tailored for managing such dietary sensitivities.

Simultaneously, the growing parental inclination toward Plant-Based and Vegan Infant Nutrition is broadening the market's reach beyond strict medical necessities into the lifestyle sector. Modern parents are increasingly prioritizing clean-label, sustainable, and animal-free nutritional options, which is driving manufacturers to enhance supply chain operations and improve the commercial feasibility of non-dairy alternatives. This movement toward ethical consumption is resulting in greater operational efficiency; for instance, Else Nutrition reported in its November 2025 Q3 financial results that its gross profit margin rose to 34%, indicating increased financial maturity within the plant-based category. Additionally, the wider industry continues to operate at a massive scale, evidenced by Abbott's 2025 report showing full-year 2024 sales of $42.0 billion, revealing the immense market capitalization that supports global innovation in pediatric nutrition.

Market Challenge

The presence of phytoestrogens in soy protein constitutes a significant obstacle to the growth of the global soy-based infant formula market due to concerns over their potential biological impact. Since these compounds naturally mimic estrogen, regulatory bodies and medical experts strictly limit the product's use, citing potential adverse risks to infant endocrine systems and long-term hormonal development. This medical caution effectively precludes soy formula from being marketed as a mainstream plant-based lifestyle option for the general infant population, instead designating it as a nutritional treatment of last resort.

As a result, soy formula is frequently omitted from the standard of care for infants under six months, which substantially reduces its potential consumer base. The market faces further constraints because soy is typically prescribed only for specific medical conditions rather than recommended for general use. According to the British Dietetic Association in 2024, the prevalence of cow's milk protein allergy in young children was estimated at just 2%, yet even within this small demographic, clinical guidelines generally favor hydrolyzed formulas over soy alternatives because of the previously mentioned safety issues. This regulatory hierarchy limits market volume by defining the product as a niche medical intervention rather than a broadly accessible nutritional choice.

Market Trends

A pivotal development in the Global Soy Based Infant Formula Market is the incorporation of prebiotics and probiotics, which directly tackles historical apprehensions regarding the digestibility of plant proteins relative to human milk. Manufacturers are increasingly enhancing soy isolates with Human Milk Oligosaccharides (HMOs) and specific bacterial strains to improve nutrient absorption and optimize the infant microbiome, thereby elevating these products from simple allergen-avoidance tools to functional nutritional solutions. This emphasis on advanced formulation is strengthening the ingredient supply chain; for example, DSM-Firmenich reported in February 2025 that its Health, Nutrition & Care business unit achieved 6% organic sales growth in 2024, driven significantly by rising demand for essential early-life nutrition ingredients such as HMOs.

In parallel, there is a distinct strategic movement toward organic and non-GMO soy sourcing, fueled by parental insistence on transparency and the exclusion of synthetic pesticides from infant diets. Because soy is often linked to genetic modification, premium brands are rigorously implementing certified organic supply chains to alleviate health concerns and distinguish their products in a competitive market. This trend is resulting in measurable category growth; according to the Organic Trade Association's April 2025 report, the organic baby food and formula sector solidified its position as the second-largest organic grocery segment with 2024 sales reaching $1.6 billion, underscoring the commercial imperative for manufacturers to obtain clean-label soy certifications.

Key Market Players

• Danone S.A.
• HiPP GmbH & Co. Vertrieb KG
• Nestle S.A.
• Abbott Laboratories
• The Kraft Heinz Company
• Reckitt Benckiser Group PLC
• Heilongjiang Feihe Dairy Co., Ltd.
• Arla Foods amba
• Kerry Group plc
• Royal FrieslandCampina N.V.

Report Scope

In this report, the Global Soy Based Infant Formula Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Soy Based Infant Formula Market, By Form

• Powder
• Liquid
• Semi-Liquid

Soy Based Infant Formula Market, By Type

• Low Fat Soy-based Infant Formula
• Whole-Fat Soy-based Infant Formula

Soy Based Infant Formula Market, By Distribution Channel

• Online
• Offline

Soy Based Infant Formula Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Soy Based Infant Formula Market.

Available Customizations:

Global Soy Based Infant Formula Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Soy Based Infant Formula Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Powder, Liquid, Semi-Liquid)
  • 5.2.2. By Type (Low Fat Soy-based Infant Formula, Whole-Fat Soy-based Infant Formula)
  • 5.2.3. By Distribution Channel (Online, Offline)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Soy Based Infant Formula Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form
  • 6.2.2. By Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Soy Based Infant Formula Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Soy Based Infant Formula Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Soy Based Infant Formula Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Soy Based Infant Formula Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form
  • 7.2.2. By Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Soy Based Infant Formula Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Soy Based Infant Formula Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Soy Based Infant Formula Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Soy Based Infant Formula Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Soy Based Infant Formula Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Soy Based Infant Formula Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form
  • 8.2.2. By Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Soy Based Infant Formula Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Soy Based Infant Formula Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Soy Based Infant Formula Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Soy Based Infant Formula Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Form
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Soy Based Infant Formula Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Form
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Soy Based Infant Formula Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form
  • 9.2.2. By Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Soy Based Infant Formula Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Soy Based Infant Formula Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Soy Based Infant Formula Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Distribution Channel

10. South America Soy Based Infant Formula Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form
  • 10.2.2. By Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Soy Based Infant Formula Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Soy Based Infant Formula Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Soy Based Infant Formula Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Soy Based Infant Formula Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danone S.A.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. HiPP GmbH & Co. Vertrieb KG
• 15.3. Nestle S.A.
• 15.4. Abbott Laboratories
• 15.5. The Kraft Heinz Company
• 15.6. Reckitt Benckiser Group PLC
• 15.7. Heilongjiang Feihe Dairy Co., Ltd.
• 15.8. Arla Foods amba
• 15.9. Kerry Group plc
• 15.10. Royal FrieslandCampina N.V.

16. Strategic Recommendations

17. About Us & Disclaimer